Tuckson Reed Vaughn has filed 15 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 2577 shares of HENRY SCHEIN INC ($HSIC) on March 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | A | Common Stock, par value $0.01 per share | 2577 | $0.00 | 12,520.0000 | 122,840,062 | 25.92% | 0.00% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | D | Stock Option (Right to Buy) | 10450 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | D | Stock Option (Right to Buy) | 4500 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | D | Stock Option (Right to Buy) | 10520 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | A | Stock Option (Right to Buy) | 10450 | $0.00 | 10,450.0000 | 19,782,000 | 9999.99% | 0.05% |
| June 11, 2025 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | F | Common Stock, par value $0.01 per share | 487 | $71.14 | 9,943.0000 | 127,779,228 | 4.67% | 0.00% |
| March 4, 2025 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | A | Common Stock, par value $0.01 per share | 2844 | $0.00 | 10,430.0000 | 127,779,228 | 37.49% | 0.00% |
| March 4, 2025 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | F | Common Stock, par value $0.01 per share | 572 | $70.31 | 7,586.0000 | 127,779,228 | 7.01% | 0.00% |
| June 17, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Tuckson Reed Vaughn | Not found | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 16,479,000 | 9999.99% | 0.06% |
| March 4, 2024 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | A | Common Stock, par value $0.01 per share | 2604 | $0.00 | 8,158.0000 | 131,748,171 | 46.89% | 0.00% |
| March 1, 2024 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Not found | F | Common Stock, par value $0.01 per share | 495 | $76.88 | 5,554.0000 | 131,748,171 | 8.18% | 0.00% |
| March 16, 2023 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Director | F | Common Stock, par value $0.01 per share | 446 | $78.15 | 6,049.0000 | 137,755,670 | 6.87% | 0.00% |
| March 1, 2023 | HENRY SCHEIN INC | $HSIC | Tuckson Reed Vaughn | Director | A | Common Stock, par value $0.01 per share | 2250 | $0.00 | 6,495.0000 | 137,755,670 | 53.00% | 0.00% |